Signal transducer and activator of transcription 3 (STAT3), which mediates biological actions in many physiological processes, is activated by cytokines and growth factors, and has been reported to be involved in the pathogenesis of various human diseases. Here, we show that treatment of HeLa cells with a histone deacetylase (HDAC) inhibitor, trichostatin A, or small-interfering RNA (siRNA)-mediated repression of HDAC3, enhances phosphorylation of STAT3 at Ser727.
Introduction
Signal transducer and activator of transcription 3 (STAT3) was originally cloned as an acute-phase response factor activated by interleukin (IL)-6 in the mouse liver, and based on its homology with STAT1 [1, 2] . Growth factors, such as epidermal growth factor and platelet-derived growth factor, can also stimulate STAT3 activity [3] . STAT3 is known to play crucial roles in early embryonic development as well as in other biological responses, including cell growth and apoptosis [4] [5] [6] .
STAT3 is constitutively activated in v-src-or v-abl-transformed cells and various primary tumors
and cell lines [7, 8] . Moreover, STAT3 itself acts as an oncogene in NIH-3T3 cells [9] . Since dysregulation of the STAT3-mediated signaling pathway is frequently detected in clinical tumor samples, understanding the mechanisms underlying STAT3 regulation of cell survival may lead to successful strategies for targeting STAT3 in cancer therapy [5, 7, 8] .
A single tyrosine residue in all STATs is phosphorylated as a consequence of cytokine or growth factor stimulation and this phosphorylation is essential for the activation of these STATs. In addition, all STATs, except for STAT2 and STAT6, are phosphorylated on serine residues in response to ligand stimulation [10] . In the case of STAT3, phosphorylation of a single serine residue (Ser727) in the transcriptional activation domain is required for maximal transcriptional activation [11] . A STAT3 S727A mutant, in which Ser727 is replaced with an alanine, exhibited a marked reduction in transcriptional activation in vivo [12] . Serine phosphorylation most likely increases STAT3 activity by increasing its association with other cofactors, such as p300 [13] . Several different kinases, including ZIP kinase, have been implicated in serine phosphorylation, implying an interaction between STAT3 signaling and serine kinase signaling pathways [10, 14] . However, the regulatory mechanisms underlying Ser727-phosphorylation of STAT3 have not yet been identified.
A recent study demonstrated that STAT3 is also acetylated on a single lysine residue, Lys685 [15] .
Histone acetyltransferase p300-mediated STAT3 acetylation on Lys685 was restored by type I histone deacetylase (HDAC). This effect was reversible by treatment of cells with trichostatin A (TSA), a broad inhibitor of HDACs. STAT3 interacted with HDAC1, HDAC2 and HDAC3.
Among them, HDAC3 displayed the strongest inhibitory effect on STAT3 deacetylase activity and bound to STAT3 through its C-terminal region, which plays a regulatory role in HDAC catalytic activity.
In the present study, we found that treatment of HeLa cells with TSA, or small-interfering RNA (siRNA)-mediated repression of HDAC3, enhances phosphorylation of STAT3 at Ser727. 
Materials and methods
Reagents and antibodies, Trichostatin A (TSA) was purchased from Wako Pure Chemicals(Osaka, Japan). Recombinant human LIF was purchased from INTERGEN (Purchase, NY). Expression vectors for STAT3, HDAC3, PP2A and STAT3-LUC were described previously [16, 17] . Anti- mixture at 37 °C for 4 h, followed by addition of fresh medium containing 10% FCS [19] . Twentyfour hrs after transfection, the cells were harvested and assayed for the luciferase activity using the Immunoprecipitation and immunoblotting, The immunoprecipitation and Western blotting assays were performed as described previously [20] . The immunoprecipitates from cell lysates were resolved on SDS-PAGE and transferred to PVDF transfer membrane (PerkinElmer; Boston, MA).
The filters were then immunoblotted with each antibody. Immunoreactive proteins were visualized using an enhanced chemiluminescence detection system (Millipore; Bedford, MA).
Results and Discussion

HDAC3 influences phosphorylation of STAT3 at Ser727
It has recently been reported that HDAC3 interacts with and deacetylates STAT3 at Lys685, and that treatment of cells with TSA enhances STAT3-mediated transcriptional activity [15] . These findings led us to examine whether HDAC3 is also involved in the regulation of phosphorylation of STAT3. To examine the involvement of HDAC3 in the phosphorylation of STAT3, we first tested the effects of TSA on the phosphorylation of STAT3. 293T or HeLa cells were pretreated with TSA for 12 h, stimulated with LIF for 30 min and analyzed for their levels of endogenous STAT3 phosphorylation. As shown in Fig. 1A and B, Ser727-phosphorylation, but not Tyr705-phosphorylation, was markedly enhanced by TSA pretreatment in both types of cells, suggesting that type I HDAC may be involved in regulating Ser727-phosphorylation, but not Tyr705-phosphorylation, of STAT3. We further investigated whether HDAC3 is involved in the regulation of STAT3 Ser727-phosphorylation using an siRNA to reduce endogenous HDAC3 expression in HeLa cells. HeLa cells were transfected with a specific siRNA against HDAC3, or a control siRNA, and aliquots of cell lysates were analyzed by Western blotting to confirm reductions in HDAC3 protein levels (Fig. 1C) . Importantly, siRNA-mediated reduced expression of HDAC3 significantly enhanced Ser727-phosphorylation, but not Tyr705-phosphorylation, of STAT3 (Fig.   1C ), further indicating that HDAC3 regulates Ser727-phosphorylation, but not Tyr705-phosphorylation, of STAT3.
HDAC3 affects phosphorylation of STAT3 at Ser727 by interacting with PP2A
In a previous study, inhibition of a major cellular serine/threonine-specific protein phosphatase, PP2A was found to induce serine phosphorylation and activation of STAT3 [21] . Furthermore, expression of PP2A antisense constructs in human hepatoma Hep3B cells was shown to enhance IL-6-induced transcription [22] . Interestingly, IL-6 stimulation activated the phosphatase activity of PP2A in Hep3B cells. Therefore, we examined whether overexpression or reduction of PP2A affects Ser727-phosphorylation of STAT3. 293T cells were transfected with expression vectors for STAT3 and PP2A, and stimulated with LIF for 30 min. As shown in Fig. 2A , Ser727-phosphorylation, but not Tyr705-phosphorylation, of STAT3, was markedly decreased by overexpression of PP2A in 293T cells. Importantly, siRNA-mediated repression of PP2A by treatment of HeLa cells with a PP2A siRNA significantly enhanced Ser727-phosphorylation, but not Tyr705-phosphorylation, of endogenous STAT3 (Fig. 2B) , confirming that PP2A regulates Ser727-phosphorylation, but not Tyr705-phosphorylation, of STAT3. Recent studies have demonstrated that another major cellular serine/threonine-specific protein phosphatase, PP1, interacts with HDACs [23] , and that a PP1-HDAC1 complex controls the functions of the transcription factor, cAMP-responsive element-binding protein (CREB) [24] . To further examine the involvement of PP2A in the HDAC3 siRNA-mediated Ser727-dephosphorylation of STAT3, we tested the effect of reducing the levels of endogenous HDAC3 on the PP2A-mediated decrease of Ser727-phosphorylation of endogenous STAT3. Expression vector for PP2A was transfected into HeLa cells treated with an siRNA for HDAC3, or a control siRNA, and stimulated with LIF for 30 min. As shown in Fig. 2C , Ser727-dephosphorylation of STAT3 by PP2A was restored by reduction of endogenous HDAC3 expression. These results indicated that HDAC3 is involved in PP2A-mediated Ser727-dephosphorylation of STAT3.
Cooperative interactions among STAT3, HDAC3 and PP2A
One of the mechanisms consistent with the above-described data is a direct interaction among STAT3, HDAC3 and PP2A. To clarify this possibility, co-immunoprecipitation experiments were performed using 293T cells, although a recent study revealed a direct interaction between STAT3 and HDAC3 [15] . Following transfection of 293T cells with expression vectors for FLAG-tagged STAT3 and Myc-tagged PP2A, the cells were lysed, and lysates were immunoprecipitated with an anti-FLAG antibody and immunoblotted with an anti-Myc antibody. As shown in Fig. 3A , a significant interaction of STAT3 with PP2A was observed, as described previously [22, 25] . When expression vectors for FLAG-tagged HDAC3 and Myc-tagged PP2A were transfected into 293T cells and the cells were lysed, immunoprecipitated with an anti-FLAG antibody and immunoblotted with an anti-Myc, the immunoprecipitates were found to contain PP2A (Fig. 3A) , indicating that direct interactions among STAT3, HDAC3 and PP2A occur in 293T cells. Next, we examined whether HDAC3 influences effective complex formation between STAT3 and PP2A to dephosphorylate STAT3. Following transfection of 293T cells with expression vectors for FLAGtagged STAT3 and Myc-tagged PP2A, with or without vector for FLAG-tagged HDAC3, the cells were lysed, and the lysates were immunoprecipitated with an anti-STAT3 antibody and immunoblotted with an anti-Myc antibody. As shown in Fig. 3B, a significantly enhanced interaction between STAT3 and PP2A was observed in the presence of HDAC3. These results indicate that HDAC3 may act as an effective reservoir for STAT3 and PP2A.
HDAC3 and PP2A are involved in regulating LIF/STAT3-mediated transactivation
To further assess the functional relevance of HDAC3 and PP2A in STAT3-mediated signaling, we examined whether siRNA-mediated reduction of endogenous HDAC3 or PP2A affects STAT3-mediated transcriptional activation by transient transfection experiments using STAT3-LUC, in which the a2-macroglobulin promoter drives expression of a luciferase (LUC) reporter gene. HeLa cells were transfected with a specific siRNA for HDAC3 or PP2A, or a control siRNA, and aliquots of cell lysates from the transfected cells were subjected to Western blot analyses, which confirmed reductions in the PP2A and HDAC3 protein contents (Fig. 4, lower panel) . As shown in 
Concluding remarks
In the present study, we have shown that HDAC3 inhibition enhances Ser727-phosphorylation of STAT3, and that STAT3, HDAC3 and PP2A form a complex. This complex formation results in Ser727-dephosphorylation of STAT3, followed by regulation of STAT3-mediated transcriptional activation.
A serine/threonine-specific protein phosphatase, PP1, has been shown to form complexes with HDAC1, HDAC6 and HDAC10 in vivo [23] . Interestingly, TSA treatment disrupted all of these cellular HDAC-PP1 complexes, suggesting that this HDAC inhibitor elicits coordinated changes in cellular protein phosphorylation and acetylation, followed by suppression of cellular functions such as cell growth and transformation. PP1 has been shown to be involved in Ser133-dephosphorylation of CREB [24] . Ser133-phosphorylation of CREB promotes the recruitment of its coactivators CBP and p300, which in turn stimulate the acetylation of promoter-bound histones to trigger further transcriptional activation. Indeed, TSA treatment enhances CREB activity by sustaining Ser133-phosphorylation via cAMP stimulation, suggesting a potential role for HDAC complexes in silencing CREB activity. Importantly, HDAC1 associates with and inhibits Ser133-phosphorylation of CREB by Ser133-dephosphorylation via an interaction with PP1. Therefore, complex formation between HDACs and PP1/2 is an important mechanism by which signaling and chromatin-modifying activities act coordinately to repress phosphorylation-dependent activation of transcription factors.
Based on the present data, we propose HDAC3 as a novel player that forms an effective complex with PP2A to regulate STAT3-mediated transactivation. Further detailed studies of STAT3-related corepressor complexes will be very important for clarifying the mechanism underlying STAT3-specific regulation of gene transcription, since STAT3 may be a key player in the pathogenesis of diverse human diseases and an important target for novel therapeutic strategies aimed at the treatment of cancer and autoimmune diseases. 2 mg) . At 36 h after transfection, the cells were stimulated with LIF (100ng/ml) for30min, and
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